Concepedia

Lewis E. Pennicott

LE

Statistics

Publications

7

Citations

585

H-Index

7

Active since

2010

Affiliations

University of Sussex(Current)

Cardiff University

GlaxoSmithKline (United States)

Novartis (United States)

Crawley Hospital

Lewis E. Pennicott is an author at University of Sussex specializing in drug discovery, medicinal chemistry, and enzyme inhibition.

ORCID

Publications per year

2010–2020

7

Publications

7

The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication

Hana Hanzlíková, Ilona Kalasová, Annie Albert Demin et al. · Molecular Cell · 2018 · 408 citations · Full text

, , +17

Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease

Xianfeng Li, Yong-Kang Zhang, Yang Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 46 citations

, , +13

Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates

Xianfeng Li, Yong-Kang Zhang, Yang Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 37 citations

, , +12

Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2

P. Hornyak, Trevor Askwith, Sarah Walker et al. · Biochemical Journal · 2016 · 37 citations · Full text

, , +14

African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase

Ryan West, Oran G. O'Doherty, Trevor Askwith et al. · European Journal of Medicinal Chemistry · 2017 · 23 citations · Full text

, , +13

1–5 of 7